Cargando…

Cost-effectiveness of Antivenoms for Snakebite Envenoming in Nigeria

BACKGROUND: Snakebite envenoming is a major public health problem throughout the rural tropics. Antivenom is effective in reducing mortality and remains the mainstay of therapy. This study aimed to determine the cost-effectiveness of using effective antivenoms for Snakebite envenoming in Nigeria. ME...

Descripción completa

Detalles Bibliográficos
Autores principales:	Habib, Abdulrazaq G., Lamorde, Mohammed, Dalhat, Mahmood M., Habib, Zaiyad G., Kuznik, Andreas
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2015
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4287484/ https://www.ncbi.nlm.nih.gov/pubmed/25569252 http://dx.doi.org/10.1371/journal.pntd.0003381

Ejemplares similares

Cost-Effectiveness of Antivenoms for Snakebite Envenoming in 16 Countries in West Africa
por: Hamza, Muhammad, et al.
Publicado: (2016)

Availability, accessibility and use of antivenom for snakebite envenomation in Africa with proposed strategies to overcome the limitations
por: Dalhat, Mahmood Muazu, et al.
Publicado: (2023)

Snakebite envenoming in different national contexts: Costa Rica, Sri Lanka, and Nigeria
por: Gutiérrez, José María, et al.
Publicado: (2021)

Antivenoms for Snakebite Envenoming: What Is in the Research Pipeline?
por: Alirol, Emilie, et al.
Publicado: (2015)

Control of snakebite envenoming: A mathematical modeling study
por: Abdullahi, Shuaibu Ahijo, et al.
Publicado: (2021)

Clinical management of snakebite envenoming: Future perspectives
por: Hamza, Muhammad, et al.
Publicado: (2021)

The Need for Next-Generation Antivenom for Snakebite Envenomation in India
por: Vanuopadath, Muralidharan, et al.
Publicado: (2023)

Newborn screening and prophylactic interventions for sickle cell disease in 47 countries in sub-Saharan Africa: a cost-effectiveness analysis
por: Kuznik, Andreas, et al.
Publicado: (2016)

Snakebite and local envenomation by Boiruna maculata treated without antivenom
por: Terashige, Shou, et al.
Publicado: (2021)

The WHO strategy for prevention and control of snakebite envenoming: a sub-Saharan Africa plan
por: Chippaux, Jean-Philippe, et al.
Publicado: (2019)

Special issue editorial: Resource mapping for the management of snakebite envenomation
por: Monteiro, Wuelton M., et al.
Publicado: (2023)

Cost of Manufacturing for Recombinant Snakebite Antivenoms
por: Jenkins, Timothy Patrick, et al.
Publicado: (2020)

Understanding and tackling snakebite envenoming with transdisciplinary research
por: Gutiérrez, José María, et al.
Publicado: (2022)

Public health aspects of snakebite care in West Africa: perspectives from Nigeria
por: Habib, Abdulrazaq G
Publicado: (2013)

Preclinical Evaluation of the Efficacy of Antivenoms for Snakebite Envenoming: State-of-the-Art and Challenges Ahead
por: Gutiérrez, José María, et al.
Publicado: (2017)

The Search for Natural and Synthetic Inhibitors That Would Complement Antivenoms as Therapeutics for Snakebite Envenoming
por: Gutiérrez, José María, et al.
Publicado: (2021)

Snakebite envenoming at MSF: A decade of clinical challenges and antivenom access issues
por: Potet, Julien, et al.
Publicado: (2022)

Predictors of depression among patients receiving treatment for snakebite in General Hospital, Kaltungo, Gombe State, Nigeria: August 2015
por: Muhammed, Abdulaziz, et al.
Publicado: (2017)

Challenges and prospects of snake antivenom supply in sub-Saharan Africa
por: Habib, Abdulrazaq G., et al.
Publicado: (2020)

Effect of the time to antivenom administration on recovery from snakebite envenoming-related coagulopathy in French Guiana
por: Houcke, Stéphanie, et al.
Publicado: (2023)

Death Adder Envenoming Causes Neurotoxicity Not Reversed by Antivenom - Australian Snakebite Project (ASP-16)
por: Johnston, Christopher I., et al.
Publicado: (2012)

Plant-Derived Toxin Inhibitors as Potential Candidates to Complement Antivenom Treatment in Snakebite Envenomations
por: Adrião, Asenate A. X., et al.
Publicado: (2022)

Antivenom access impacts severity of Brazilian snakebite envenoming: A geographic information system analysis
por: Isaacson, Julia Elizabeth, et al.
Publicado: (2023)

Clinical Effects and Antivenom Dosing in Brown Snake (Pseudonaja spp.) Envenoming — Australian Snakebite Project (ASP-14)
por: Allen, George E., et al.
Publicado: (2012)

Randomised Controlled Double-Blind Non-Inferiority Trial of Two Antivenoms for Saw-Scaled or Carpet Viper (Echis ocellatus) Envenoming in Nigeria
por: Abubakar, Isa S., et al.
Publicado: (2010)

Using Geographical Information Systems to Identify Populations in Need of Improved Accessibility to Antivenom Treatment for Snakebite Envenoming in Costa Rica
por: Hansson, Erik, et al.
Publicado: (2013)

Acute Severe Anaphylaxis in Nepali Patients with Neurotoxic Snakebite Envenoming Treated with the VINS Polyvalent Antivenom
por: Sharma, Sanjib Kumar, et al.
Publicado: (2019)

Dose of antivenom for the treatment of snakebite with neurotoxic envenoming: Evidence from a randomised controlled trial in Nepal
por: Alirol, Emilie, et al.
Publicado: (2017)

Snakebite is Under Appreciated: Appraisal of Burden from West Africa
por: Habib, Abdulrazaq G., et al.
Publicado: (2015)

Situation of snakebite, antivenom market and access to antivenoms in ASEAN countries
por: Patikorn, Chanthawat, et al.
Publicado: (2022)

Cost-effectiveness of expanding childhood routine immunization against Neisseria meningitidis serogroups C, W and Y with a quadrivalent conjugate vaccine in the African meningitis belt
por: Kuznik, Andreas, et al.
Publicado: (2017)

Snakebite Envenoming Diagnosis and Diagnostics
por: Knudsen, Cecilie, et al.
Publicado: (2021)

Recent Advances in Next Generation Snakebite Antivenoms
por: Knudsen, Cecilie, et al.
Publicado: (2018)

Strategy for a globally coordinated response to a priority neglected tropical disease: Snakebite envenoming
por: Williams, David J., et al.
Publicado: (2019)

Biosynthetic Oligoclonal Antivenom (BOA) for Snakebite and Next-Generation Treatments for Snakebite Victims †
por: Kini, R. Manjunatha, et al.
Publicado: (2018)

Antibodies as Snakebite Antivenoms: Past and Future
por: Dias da Silva, Wilmar, et al.
Publicado: (2022)

Antibiotic therapy for snakebite envenoming
por: Resiere, Dabor, et al.
Publicado: (2020)

Recombinant snakebite antivenoms: A cost-competitive solution to a neglected tropical disease?
por: Laustsen, Andreas H., et al.
Publicado: (2017)

Role of GeneXpert MTB/Rif Assay in Diagnosing Tuberculosis in Pregnancy and Puerperium
por: Habib, Zaiyad G., et al.
Publicado: (2015)

Delayed Psychological Morbidity Associated with Snakebite Envenoming
por: Williams, Shehan S., et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_c2ee3vndjvmamcgsl85fbb2tkl